Innoviva Inc (INVA)
15.79
-0.29
(-1.80%)
USD |
NASDAQ |
May 23, 16:00
15.78
-0.01
(-0.06%)
After-Hours: 20:00
Innoviva Free Cash Flow: 152.43M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | 152.43M |
| December 31, 2023 | 140.65M |
| September 30, 2023 | 116.41M |
| June 30, 2023 | 88.38M |
| March 31, 2023 | 129.22M |
| December 31, 2022 | 201.66M |
| September 30, 2022 | 291.18M |
| June 30, 2022 | 372.21M |
| March 31, 2022 | 377.80M |
| December 31, 2021 | 363.81M |
| September 30, 2021 | 350.71M |
| June 30, 2021 | 328.56M |
| March 31, 2021 | 323.74M |
| December 31, 2020 | 313.10M |
| September 30, 2020 | 294.72M |
| June 30, 2020 | 277.57M |
| March 31, 2020 | 254.27M |
| December 31, 2019 | 257.46M |
| September 30, 2019 | 252.33M |
| June 30, 2019 | 255.04M |
| March 31, 2019 | 250.27M |
| December 31, 2018 | 223.53M |
| September 30, 2018 | 209.61M |
| June 30, 2018 | 192.99M |
| March 31, 2018 | 163.90M |
| Date | Value |
|---|---|
| December 31, 2017 | 141.75M |
| September 30, 2017 | 114.95M |
| June 30, 2017 | 91.40M |
| March 31, 2017 | 81.22M |
| December 31, 2016 | 60.71M |
| September 30, 2016 | 46.56M |
| June 30, 2016 | 29.27M |
| March 31, 2016 | 19.00M |
| December 31, 2015 | 10.12M |
| September 30, 2015 | -1.535M |
| June 30, 2015 | 74.74M |
| March 31, 2015 | -80.78M |
| December 31, 2014 | -131.41M |
| September 30, 2014 | -127.71M |
| June 30, 2014 | -258.19M |
| March 31, 2014 | -152.22M |
| December 31, 2013 | -132.34M |
| September 30, 2013 | -155.81M |
| June 30, 2013 | -132.39M |
| March 31, 2013 | -120.04M |
| December 31, 2012 | -130.10M |
| September 30, 2012 | -131.85M |
| June 30, 2012 | -123.01M |
| March 31, 2012 | -107.12M |
| December 31, 2011 | -91.97M |
Free Cash Flow Range, Past 5 Years
88.38M
Minimum
Jun 2023
377.80M
Maximum
Mar 2022
257.06M
Average
267.51M
Median
Free Cash Flow Benchmarks
| NovaBay Pharmaceuticals Inc | -4.524M |
| Palatin Technologies Inc | -33.83M |
| iBio Inc | -18.67M |
| Theriva Biologics Inc | -18.27M |
| Oragenics Inc | -8.246M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 37.05M |
| Cash from Investing (Quarterly) | -43.04M |
| Cash from Financing (Quarterly) | -9.165M |
| Free Cash Flow Per Share (Quarterly) | 0.4383 |
| Free Cash Flow to Equity (Quarterly) | 36.52M |
| Free Cash Flow to Firm (Quarterly) | 38.22M |
| Free Cash Flow Yield | 12.03% |